A Phase I Clinical Study to Evaluate the Efficacy and Safety of GB18 Injection in Patients With Tumor Cachexia
Clinical trial NCT07519564 · RECRUITING
Trial details
- NCT number
- NCT07519564
- Sponsor
- Kexing Biopharm Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-10
- Primary completion
- 2027-09-30
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.